07 Jun 2022 --- Capra Biosciences has raised US$1.8 million in a pre-seed funding round to be channeled into expanding its patented bioreactor technology for making petrochemical replacements. The technology creates chemicals using “natural processes” and consumes waste from other products to transform them.
